Visit cardinalhealth.com for more information about Cardinal Health »
In December 2020, the FDA announced that a new radioactive diagnostic agent, Gallium 68 (Ga-68) PSMA-11, could be prescribed and administered to patients with suspected prostate cancer metastasis...
Return to top
